Search research articles
Contact Us
Filters
Showing results (151-160 of 391) with videos related to
Page
of 40
Sort By:
Frontiers in Neurology
|
April 7, 2018
Amyloid-β Plaques in Clinical Alzheimer's Disease Brain Incorporate Stable Isotope Tracer <i>In Vivo</i> and Exhibit Nanoscale Heterogeneity
Norelle C Wildburger, Frank Gyngard, Christelle Guillermier, et al.
Brain Communications
|
December 19, 2025
Stable isotope labelling kinetics of neurofilament light
Claire A Leckey, Tatiana A Giovannucci, John B Coulton, et al.
Toxicology and Applied Pharmacology
|
March 19, 2017
The effect of angiotensin receptor neprilysin inhibitor, sacubitril/valsartan, on central nervous system amyloid-β concentrations and clearance in the cynomolgus monkey
Heidi A Schoenfeld, Tim West, Philip B Verghese, et al.
Journal of Alzheimer'S Disease : JAD
|
April 26, 2012
Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease
Erik Portelius, Henrik Zetterberg, Robert A Dean, et al.
Annals of Neurology
|
June 5, 2015
Age and amyloid effects on human central nervous system amyloid-beta kinetics
Bruce W Patterson, Donald L Elbert, Kwasi G Mawuenyega, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 10, 2016
Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials
Stacie Weninger, Maria C Carrillo, Billy Dunn, et al.
Genome Medicine
|
June 9, 2018
Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure
Zeran Li, Jorge L Del-Aguila, Umber Dube, et al.
Annals of Clinical and Translational Neurology
|
November 5, 2020
Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease
Charles D Chen, Timothy R Holden, Brian A Gordon, et al.
Annals of Clinical and Translational Neurology
|
October 2, 2022
Comparison of plasma and CSF biomarkers in predicting cognitive decline
Andrew J Aschenbrenner, Yan Li, Rachel L Henson, et al.
Science Translational Medicine
|
June 14, 2013
Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers
Rachel Potter, Bruce W Patterson, Donald L Elbert, et al.
Page
of 40
Search research articles
Search
Showing results (151-160 of 391) with videos related to
Sort By:
Page
of 40
Frontiers in Neurology
|
April 7, 2018
Amyloid-β Plaques in Clinical Alzheimer's Disease Brain Incorporate Stable Isotope Tracer <i>In Vivo</i> and Exhibit Nanoscale Heterogeneity
Norelle C Wildburger, Frank Gyngard, Christelle Guillermier, et al.
Brain Communications
|
December 19, 2025
Stable isotope labelling kinetics of neurofilament light
Claire A Leckey, Tatiana A Giovannucci, John B Coulton, et al.
Toxicology and Applied Pharmacology
|
March 19, 2017
The effect of angiotensin receptor neprilysin inhibitor, sacubitril/valsartan, on central nervous system amyloid-β concentrations and clearance in the cynomolgus monkey
Heidi A Schoenfeld, Tim West, Philip B Verghese, et al.
Journal of Alzheimer'S Disease : JAD
|
April 26, 2012
Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease
Erik Portelius, Henrik Zetterberg, Robert A Dean, et al.
Annals of Neurology
|
June 5, 2015
Age and amyloid effects on human central nervous system amyloid-beta kinetics
Bruce W Patterson, Donald L Elbert, Kwasi G Mawuenyega, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 10, 2016
Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials
Stacie Weninger, Maria C Carrillo, Billy Dunn, et al.
Genome Medicine
|
June 9, 2018
Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure
Zeran Li, Jorge L Del-Aguila, Umber Dube, et al.
Annals of Clinical and Translational Neurology
|
November 5, 2020
Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease
Charles D Chen, Timothy R Holden, Brian A Gordon, et al.
Annals of Clinical and Translational Neurology
|
October 2, 2022
Comparison of plasma and CSF biomarkers in predicting cognitive decline
Andrew J Aschenbrenner, Yan Li, Rachel L Henson, et al.
Science Translational Medicine
|
June 14, 2013
Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers
Rachel Potter, Bruce W Patterson, Donald L Elbert, et al.
Page
of 40